{
    "clinical_study": {
        "@rank": "131113", 
        "arm_group": [
            {
                "arm_group_label": "symbiotic", 
                "arm_group_type": "Experimental", 
                "description": "symbiotic preparation 1/2 sachet twice daily during 30 days"
            }, 
            {
                "arm_group_label": "distilled water", 
                "arm_group_type": "Placebo Comparator", 
                "description": "2 x 0.5 cc distilled water will be given during 30 days"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this prospective double blinded randomised study is to investigate the efficacy\n      of symbiotic preparation which contains lactobacillus casei, L. rhamnosus, L. plantarum,\n      Bifidobacterium lactis, fructo and galactooligosaccharide on cytokines as interferon-gama\n      acting on Th1 pathway, interleukin -5 acting on Th2, interleukin -10 acting on T regulatory\n      pathway,  and interleukin -17 acting on Th-17 pathway that were related with necrotizing\n      enterocolitis pathogenesis in very low birth weight neonates."
        }, 
        "brief_title": "The Efficacy of Symbiotic on Cytokines", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Necrotising Enterocolitis", 
        "condition_browse": {
            "mesh_term": [
                "Enterocolitis", 
                "Enterocolitis, Necrotizing"
            ]
        }, 
        "detailed_description": {
            "textblock": "Inclusion criteria:\n\n        1. Neonates who born 26- 32 gestational week and 750-1500 gram birth weights\n\n        2. Neonates who tolerated minimal enteral feeding within postnatal first week\n\n      Exclusion criteria:\n\n        1. PROM> 24 hours and/or chorioamnionitis\n\n        2. Mechanic ventilation supply more than 7 days\n\n        3. Culture proven sepsis\n\n        4. Major congenital anomaly\n\n        5. Patients undergoing surgery\n\n      Intervention:\n\n      The allocations will contain in opaque, sequentially numbered sealed envelopes. The study\n      group will receive symbiotic preparation (Probiotic ATP, Nobel,  1/2 sachet twice daily);\n      whereas the control group will receive placebo (distilled water; 1 ml per dose twice daily)\n      which will be added to breast milk or formula starting with the first feed.0.5 cc blood\n      sampling will be taken from patients within postnatal 48 hours, 14+2.days, 28+2.days. This\n      samples will turn by cold centrifugation and store at -20 \u00b0C temperature. The cytokines will\n       be analysed by ELISA multiplex method."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Neonates born 26- 32 GWs and 750-1500 gram birth weights\n\n          2. Neonates who tolerated minimal enteral feeding during first week of life\n\n        Exclusion Criteria:\n\n          1. PROM> 24 hour and/or chorioamnionitis\n\n          2. Mechanical ventilation supply more than 7 days\n\n          3. Culture proven sepsis\n\n          4. Major congenital anomaly\n\n          5. Neonates undergoing surgery"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "2 Days", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01899677", 
            "org_study_id": "14893"
        }, 
        "intervention": [
            {
                "arm_group_label": "distilled water", 
                "description": "0.5 cc distilled water twice daily will be added to the breast milk or formula during 30 days", 
                "intervention_name": "distilled water", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "symbiotic", 
                "description": "Symbiotic 1/2 sachet twice daily will be added to the breast milk or formula during 30 days", 
                "intervention_name": "symbiotic", 
                "intervention_type": "Drug", 
                "other_name": "Probiotic ATP"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Symbiotic,cytokines, necrotising enterocolitis", 
        "lastchanged_date": "July 12, 2013", 
        "location": {
            "contact": {
                "email": "fovali@yahoo.com", 
                "last_name": "Fahri Ovali, Proff", 
                "phone": "+9005324116715"
            }, 
            "facility": {
                "address": {
                    "city": "Istanbul", 
                    "country": "Turkey", 
                    "state": "Umraniye", 
                    "zip": "34668"
                }, 
                "name": "Zeynep Kamil Maternity and Child Health Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Ozge Serce, Specialist", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Fahri Ovali, Proff", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Tugba Gursoy, Assoc. Prof.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Derya Benzer, Specialist", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Efficacy of Symbiotic Preparation on Cytokines Which Act on Necrotising Enterocolitis Pathogenesis in Very Low Birth Weight Infants", 
        "overall_contact": {
            "email": "fovali@yahoo.com", 
            "last_name": "Fahri Ovali"
        }, 
        "overall_official": [
            {
                "affiliation": "Zeynep Kamil Maternity and Childen Education and Training Hospital", 
                "last_name": "Fahri Ovali", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Zeynep Kamil Maternity and Childen Education and Training Hospital", 
                "last_name": "Ozge Serce", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Zeynep Kamil Maternity and Children Education and Training Hospital", 
                "last_name": "Tugba Gursoy, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Turkey: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Targeted cytokine blood levels via symbiotics", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "reference": {
            "PMID": "18626975", 
            "citation": "Ng SC, Hart AL, Kamm MA, Stagg AJ, Knight SC. Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis. 2009 Feb;15(2):300-10. doi: 10.1002/ibd.20602. Review."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01899677"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Zeynep Kamil Maternity and Pediatric Research and Training Hospital", 
            "investigator_full_name": "Ozge Serce", 
            "investigator_title": "specialist in neonatology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Zeynep Kamil Maternity and Pediatric Research and Training Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Zeynep Kamil Maternity and Pediatric Research and Training Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}